Ocular Delivery

Thursday, July 11, 2024

3:30 PM – 5:30 PM CET

Location: Magenta A

Sponsored By

"Lipid nanoparticles for non-immunogenic mRNA delivery to the retina" will present the potential of intravitreal injected LNPs to deliver reporter mRNA encoding eGFP to the retina, together with the in vitro, ex vivo and in vivo methodologies used to screen LNP formulations.

Chair(s)

Katelyn E. Swindle-Reilly, PhD (she/her/hers)

Associate Professor / Chief Technology Officer
The Ohio State University / Vitranu
Columbus, Ohio, United States

Co-Chair(s)

Crystal Shin, PhD (she/her/hers)

Assistant Professor
Baylor College of Medicine
Houston, Texas, United States

Invited Speaker(s)

Ilva Dana Rupenthal (she/her/hers)

Associate Professor
The University of Auckland
Auckland, New Zealand

Oral Abstract Speaker(s)

Carmen Alvarez-Lorenzo (she/her/hers)

Full Professor
Universidade de Santiago de Compostela
Santiago de Compostela, Spain

PDF Handouts
Arto Merivaara, PharmD

Postdoctoral researcher
University of Eastern Finland
Kuopio, Finland

PDF Handouts
Katrien Remaut, Pharmaceutical Sciences (she/her/hers)

Associate professor
Ghent University
Gent, Belgium

Handouts
Lalitkumar K. K. Vora, MPharm, PhD (he/him/his)

Lecturer in Pharmaceutics
Queen's university Belfast
Belfast, United Kingdom

Handouts
GA

Ghanashyam Acharya, PhD

Associate Professor
Baylor College of Medicine, Texas, United States

PDF Handouts

Local Chapter Speaker(s)

Silvia Pescina, PhD (she/her/hers)

Associate Professor
University of Parma
Parma, Italy

Handouts

Abstract Poster Presenter(s)

Sandeep Nema, PhD

SVP
SalioGen Therapeutics
Lexington, Massachusetts, United States

Handouts
Tais Gratieri, PhD

Associate Professor
University of Brasilia
Brasilia , Brazil

PDF Handouts
María Lina L. Formica, PhD (she/her/hers)

Assistant Researcher-Assistant Professor
National University of Cordoba-UNITEFA, CONICET, Cordoba, Argentina

PDF Handouts
Valerie Eta, DSc (he/him/his)

Development Scientist
Rebio Pharma
Raisio, Finland

PDF Handouts